new glp 1 drugs 2025 GLP-1 drug access and 2026 health benefits: What consumers expect survey data shows 59% of Americans support the Trump administration's plan to broaden access to GLP-1 for weight-loss at discounted Pharma Giants Bet on Next-Generation

The impact of these changes on GLP-1s purchased through employer sponsored health plans is not yet clear

Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress

Differential Effects of Oxyntomodulin and GLP-1 on Glucose Metabolism

Anti-obesity medications help our patients focus on creating sustainable behaviors that support a healthy weight and lifestyle, without the distractions of hunger and cravings

Intrapyloric injection of botulinum toxin is not recommended for patients with gastroparesis based on randomized controlled trials